- Postdoctoral fellow, Biology of Aging, University of Southern California, 2019
- PhD, Systems Biology, Yonsei University, South Korea, 2012
- BS, Biotechnology, Yonsei University, South Korea, 2005
- Mitochondrial-derived peptides
- Parkinson’s disease
Su-Jeong Kim, PhD, researches the functional roles of mitochondrial DNA variants in age-related diseases or the therapeutic potential of mitochondrial-derived peptides in age-related diseases. She trained in the field of Parkinson’s disease (PD) during her Ph.D. and currently focus on the roles of mtDNA SNP and a mitochondrial peptide called SHLP2 in PD. She uses a population-based database, human cell culture, and mice models in her research. She also investigates the key features of mitochondrial physiology, mitochondrial-derived peptides, and mitochondrial long noncoding RNAs and its binding proteins during cellular senescence. She is studying the importance of the mitochondrial alteration during senescence and the senolytics targets.